Presented by Alessandro Fichera, MD at the SAGES 2013 Annual Meeting; SAGES/ISLCRS Panel: IBD
outline–52 sec
epidemiology–1:19 https://www.ncbi.nlm.nih.gov/pubmed/11910338
https://www.ncbi.nlm.nih.gov/pubmed/7429313
classification–2:59 https://www.ncbi.n
Keyword(s): abscesses, ABX, ACCENT 1 trial, adalimumab, adipose-derived stem cells, advancement flap, algorithm, anal canal, anal fistulae, anal fistulas, Annals of Internal Medicine, anorectal complications, anorectal fistulae, anti-TNF alpha local therapy, anti-TNF antibodies, antibody, Archives of Surgery, azathioprine, biologic agents, biologics, CD, CD161, CD4, clinical research, collagen fistula plug, Colorectal Diseases, complex perianal fistula, cyclosporine, DCR, definitive surgical tx, drain, drain placement, DRE, efficacy, emerging tx, epidemiology, EUA, extrasphincteric, fibrin adhesive, fibrin glue injection, fibrin sealant, fistula tracks, fistulas-in-ano, fistulizing CD, fistulotomy, Gastroenterology, GI, Gut, H&P, I&D, IBD, imaging modality, incidence, infliximab, International Archives of Allergy & Immunology, intersphinteric, intestinal disease, ISLCRS, Lancet, LIFT procedure, local injection, long-term f/u, luminal disease, mandatory, medical therapy, mercaptopurine, morbidity, MRI, natural hx, NEJM, Parks classification system, perianal CD, perianal disease, perianal fistulas, perineum, phase II clinical trial, physical exam, pilot study, plug, primary tx, proctectomy, proctitis, proctocolectomy, pt population, radomised trial, rectal disease, rectal involvement, rectovaginal fistulas, rectum, remission, SB disease, Scandinavian Journal of Gastroenterology, sedation, sepsis, seton placement, stem cells, suprasphincteric, surgical options, surgical tx, systematic review, T lymphocytes, tacrolimus, TNF-alpha, trans-sphincteric, transrectal approach, transvaginal approach, tx planning, US, vagina, World Journal of Gastroenterology